New York A 10747: Relates to remedial program requirements

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A10747 Summary:

BILL NOA10747 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORReyes

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §§3216, 3221 & 4303, Ins L

&nbsp

Requires health insurance plans to cover a medically necessary peripheral artery disease screening test for any at-risk individual; prohibits imposition of patient cost sharing for follow-up screenings or diagnostics.

Go to top A10747 Actions:

BILL NOA10747 

&nbsp

03/27/2026referred to insurance

Go to topA10747 Committee&nbspVotes:

Go to topA10747 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA10747 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 10747

 IN ASSEMBLY

 March 27, 2026
 ___________

 Introduced by M. of A. REYES -- read once and referred to the Committee
 on Insurance

 AN ACT to amend the insurance law, in relation to requiring health
 insurance plans to cover a medically necessary peripheral artery
 disease screening test for any at-risk individual

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Subsection (i) of section 3216 of the insurance law is
 2 amended by adding a new paragraph 42 to read as follows:
 3 (42) (A) Every policy which provides medical, major medical, or simi-
 4 lar comprehensive-type coverage shall provide medically necessary cover-
 5 age for a peripheral artery disease screening test for any at-risk indi-
 6 vidual, as defined by the American College of Cardiology and the
 7 American Heart Association's joint committee on clinical practice guide-
 8 lines.
 9 (B) Notwithstanding any other provision of law, any policy that
 10 provides coverage required by this paragraph shall not impose patient
 11 cost sharing for follow-up screening or diagnostic services for periph-
 12 eral artery disease.
 13 (C) (i) Nothing in this paragraph shall be construed to prevent
 14 medical management or utilization review of the services, including
 15 preauthorization, to ensure that such services are consistent with
 16 nationally recognized clinical practice guidelines for the detection of
 17 peripheral artery disease.
 18 (ii) For the purposes of this subparagraph, the term "nationally
 19 recognized clinical practice guidelines" means evidence-based, peer
 20 reviewed clinical practice guidelines informed by a systematic review of
 21 evidence and an assessment of the benefits, and risks of alternative
 22 care options intended to optimize patient care developed by independent
 23 organizations or medical professional societies utilizing a transparent
 24 methodology and reporting structure and with a conflict of interest
 25 policy.
 26 (D) If the policy is a high deductible health plan as defined in
 27 section 223(c)(2) of the Internal Revenue Code of 1986, such coverage

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD15315-01-6

 A. 10747 2

 1 may be subject to the plan's annual deductible if application of this
 2 requirement would result in ineligibility for a health savings account.
 3 § 2. Subsection (l) of section 3221 of the insurance law is amended by
 4 adding a new paragraph (24) to read as follows:
 5 (24) (A) Every policy which provides medical, major medical, or simi-
 6 lar comprehensive-type coverage shall provide medically necessary cover-
 7 age for a peripheral artery disease screening test for any at-risk indi-
 8 vidual, as defined by the American College of Cardiology and the
 9 American Heart Association's joint committee on clinical practice guide-
 10 lines.
 11 (B) Notwithstanding any other provision of law, any policy that
 12 provides coverage required by this paragraph shall not impose patient
 13 cost sharing for follow-up screening or diagnostic services for periph-
 14 eral artery disease.
 15 (C) (i) Nothing in this paragraph shall be construed to prevent
 16 medical management or utilization review of the services, including
 17 preauthorization, to ensure that such services are consistent with
 18 nationally recognized clinical practice guidelines for the detection of
 19 peripheral artery disease.
 20 (ii) For the purposes of this subparagraph, the term "nationally
 21 recognized clinical practice guide